Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance

References

• MazurAAn enzyme in animal tissues capable of hydrolysing the phosphorus-fluorine bond of alkyl fluorophosphatesJ Biol Chem194616427128920989488
   PubMed Web of Science ®Google Scholar
• AldridgeWNSerum esterases 2-An enzyme hydrolysing diethyl p-nitrophenylphosphate (E600) and its identity with the A-esterase of mammalian seraBiochem J19535311712413032042
   PubMed Web of Science ®Google Scholar
• MacknessMMacknessBHuman Paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological rolesGene20155671122125965560
   PubMed Web of Science ®Google Scholar
• PrécourtLPAmreDDenisMCThe three-gene paraoxonase family: physiologic roles, actions and regulationAtherosclerosis20112141203620934178
   PubMed Web of Science ®Google Scholar
• MacknessMIArrolSDurringtonPNParaoxonase prevents accumulation of lipoperoxides in low-density lipoproteinFEBS Lett19912861521541650712
   PubMed Web of Science ®Google Scholar
• MacknessMIAbbottCAArrolSDurringtonPNThe role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidationBiochem J1993a2948298348379937
   PubMed Web of Science ®Google Scholar
• MacknessMIArrolSAbbottCAProtection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis19931041291358141836
   PubMed Web of Science ®Google Scholar
• Perła-KajánJJakubowskiHParaoxonase 1 and homocysteine metabolismAmino Acids20124341405141722643843
   PubMed Web of Science ®Google Scholar
• Blaha-NelsonDKrügerDMSzelerKActive site hydrophobicity and the convergent evolution of paraoxonase activity in structurally divergent enzymes: the case of serum paraoxonase 1J Am Chem Soc201713931155116728026940
   PubMed Web of Science ®Google Scholar
• VitariusJASultatosLGThe role of calcium in the hydrolysis of the organophosphate paraoxon by human serum A-esteraseLife Sci19955621251347823759
   PubMed Web of Science ®Google Scholar
• Primo-ParmaSLSorensonRCTeiberJLa DuBNThe human serum araoxonase/arylesterase gene (PON1) is one member of a multigene familyGenomics1996334985098661009
   PubMed Web of Science ®Google Scholar
• Rodríguez-SanabriaFRullABeltrán-DebónRTissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated roleJ Mol Histol201041637938620931267
   PubMed Web of Science ®Google Scholar
• AviramMRosenblatMParaoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis developmentFree Radic Biol Med20043791304131615454271
   PubMed Web of Science ®Google Scholar
• NajafiMGohariLHFiroozraiMParaoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteriesThromb Res2009123350351018433845
   PubMed Web of Science ®Google Scholar
• Ponce-RuizNMurillo-GonzálezFERojas-GarcíaAETranscriptional regulation of human Paraoxonase 1 by nuclear receptorsChem Biol Interact2017268778428223025
   PubMed Web of Science ®Google Scholar
• HumbertRAdlerDADistecheCMThe molecular basis of the human serum paraoxonase activity polymorphismNat Genet19933173768098250
   PubMed Web of Science ®Google Scholar
• Blatter GarinMCJamesRWDussoixPParaoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetesJ Clin Invest199799162669011577
   PubMed Web of Science ®Google Scholar
• CostaLGColeTBVitaloneAFurlongCEMeasurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicityClin Chim Acta20053521–2374715653099
   PubMed Web of Science ®Google Scholar
• DounousiEBoubaISpotoBA genetic biomarker of oxidative stress, the Paraoxonase-1 Q192R gene variant, associates with cardiomyopathy in CKD: a longitudinal studyOxid Med Cell Longev20162016150727027313824
   PubMed Web of Science ®Google Scholar
• MacknessBTurkieWMacknessMParaoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heartdiseaseArch Med Sci20139181323515649
   PubMed Web of Science ®Google Scholar
• GetzGSReardonCAParaoxonase, a cardioprotective enzyme: continuing issuesCurr Opin Lipidol200415326126715166781
   PubMed Web of Science ®Google Scholar
• ChistiakovDAMelnichenkoAAOrekhovANBobryshevYVParaoxonase and atherosclerosis-related cardiovascular diseasesBiochimie2017132192727771368
   PubMed Web of Science ®Google Scholar
• TwardAXiaYRWangXPDecreased atherosclerotic lesion formation in human serum paraoxonase transgenic miceCirculation2002106448449012135950
   PubMed Web of Science ®Google Scholar
• ShihDMGuLXiaYRMice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosisNature19983942842879685159
   PubMed Web of Science ®Google Scholar
• AzarsizEKayikciogluMPayzinSYildirim SözmenEPON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery diseaseInt J Cardiol2003911435112957728
   PubMed Web of Science ®Google Scholar
• SharmaRSinghBMahajanMPON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery diseaseKaohsiung J Med Sci200723522523117525004
   PubMed Web of Science ®Google Scholar
• HanYDorajooRKeTInteraction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese populationAtherosclerosis20152401404525746376
   PubMed Web of Science ®Google Scholar
• KunutsorSKBakkerSJJamesRWDullaartRPSerum paraoxonase-1 activity and risk of incident cardiovascular disease: the PREVEND study and meta-analysis of prospective population studiesAtherosclerosis201624514315426724525
   PubMed Web of Science ®Google Scholar
• SeresIParaghGDescheneEFulopTJrKhalilAStudy of factors influencing the decreased HDL associated PON1 activity with agingExp Gerontol2004391596614724065
   PubMed Web of Science ®Google Scholar
• LescaiFMarchegianiFFranceschiCPON1 is a longevity gene: results of a meta-analysisAgeing Res Rev20098427728419376276
   PubMed Web of Science ®Google Scholar
• CaliebeAKleindorpRBlanchéHNo or only population-specific effect of PON1 on human longevity: a comprehensive meta-analysisAgeing Res Rev20109323824420362697
   PubMed Web of Science ®Google Scholar
• WeiGZZhuMYWangFParaoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: a meta-analysisZ Gerontol Geriatr2016491243125962362
   PubMed Web of Science ®Google Scholar
• ZhangMXiongHFangLParaoxonase 1 (PON1) Q192R gene polymorphism and cancer risk: a meta-analysis based on 30 publicationsAsian Pac J Cancer Prev201516104457446326028114
   PubMedGoogle Scholar
• BaynesJWRole of oxidative stress in development of complications in diabetesDiabetes1991404054122010041
   PubMed Web of Science ®Google Scholar
• GuptaNBinukumarBKSinghSSerum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian populationGene2011487889521803130
   PubMed Web of Science ®Google Scholar
• HedrickCCThorpeSRFuM-XGlycation impairs high density lipoprotein functionDiabetologia20004331232010768092
   PubMed Web of Science ®Google Scholar
• SinghDVenketeshSVermaJSLellammaCOGoelRCParaoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitusIndian J Med Res200712578378717704557
   PubMed Web of Science ®Google Scholar
• El-SaidaNENasr-AllahaMMSadikaNASharafSAParaoxonase-1 activity in type 2 diabetes mellitus with and without nephropathyEgypt J Intern Med2015276368
   Google Scholar
• NamithaDNusrathARajeshwariARaniNASerum paraoxonase levels in type 2 diabetes mellitus patients: a case control studyJ Med Sci Health2015121418
   Google Scholar
• FlekacMSkrhaJZidkovaKLacinováZHilgertováJParaoxonase 1 gene polymorphism and enzyme activities in diabetes mellitusPhysiol Res20085771772617949258
   PubMed Web of Science ®Google Scholar
• RozekLSHatsukamiTSRichterRJThe correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease statusJ Lipid Res20054691888189515995178
   PubMed Web of Science ®Google Scholar
• JarvikGPHatsukamiTSCarlsonCParaoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular diseaseArterioscler Thromb Vasc Biol2003231465147112805074
   PubMed Web of Science ®Google Scholar
• RectorRSWarnerSOLiuYExercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndromeAm J Physiol Endocrinol Metab2007293E500E50617473052
   PubMed Web of Science ®Google Scholar
• AmunaRAMythiliSVShunmugamNStudy on Paraoxonase 1 in type 2 diabetes mellitusIndian J Physiol Pharmacol2014581131625464671
   PubMedGoogle Scholar
• NieYLuoDYangMA meta-analysis on the relationship of the PON genes and Alzheimer diseaseJ Geriatr Psychiatry Neurol201730630331028954597
   PubMed Web of Science ®Google Scholar
• LiuHXiaPLiuMPON gene polymorphisms and ischaemic stroke: a systematic review and meta analysisInt J Stroke20138211112322631428
   PubMed Web of Science ®Google Scholar
• RichardSAFrankEAD’SouzaCJCorrelation between cholinesterase and Paraoxonase 1 activities: case Series of pesticide poisoning subjectsBioimpacts20133311912224163803
   PubMedGoogle Scholar
• MahroozAPharmacological interactions of Paraoxonase 1 (PON1): a HDL-bound antiatherogenic enzymeCurr Clin Pharmacol201611425926427633038
   PubMedGoogle Scholar
• BoumanHJSchömigEvan WerkumJWParaoxonase-1 is a major determinant of clopidogrel efficacyNat Med201117111011621170047
   PubMed Web of Science ®Google Scholar
• RenyJLCombescureCDaaliYFontanaPPON1 Meta-Analysis GroupPON1 Meta-Analysis Group. Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysisJ Thromb Haemost2012101242125122520065
   PubMed Web of Science ®Google Scholar
• MegaJLCloseSLWiviottSDPON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJ Thromb Thrombolysis20164137438326573179
   PubMed Web of Science ®Google Scholar